Promega Corporation: SARS-CoV-2 Antibody Test Developed by Promega Receives CE Mark
Novel bioluminescent Lumit Dx SARS-CoV-2 Immunoassay enables simple, scalable antibody detection
A SARS-CoV-2 antibody test developed by Promega Corporation, the Lumit Dx SARS-CoV-2 Immunoassay, has received CE marking and is now available in Europe. The novel bioluminescent immunoassay is a qualitative in vitro diagnostic test intended to detect antibodies to SARS-CoV-2 in serum.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210609005062/en/
The Lumit Dx SARS-CoV-2 Immunoassay by Promega has received CE marking. The novel bioluminescent immunoassay is a qualitative in vitro diagnostic test intended to detect antibodies to SARS-CoV-2 in serum. (Photo: Business Wire)
Promega launches XpressAmp™ Direct Amplification Reagents news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
Combined CDC COVID-19/Influenza Test Amended to Include Promega Maxwell® RSC 48 and CSC 48 Instruments, Maxwell® RSC Viral Total Nucleic Acid Purification Kit
on January 14 2021 1:00 AM
Expanded list of authorized instruments and reagents allows more options for labs running CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay
MADISON, Wis. (BUSINESS WIRE) #COVID19 Labs performing the Centers for Disease Control’s (CDC) Flu SC2 Multiplex Assay, a single test to diagnose infection caused by SARS-CoV-2, influenza A, or influenza B, can now use two Promega instruments and a Promega nucleic acid purification kit in the protocol. In a letter dated January 8, 2021, the US Food and Drug Administration (FDA) authorized an amendment to the Emergency Use Authorization (EUA) for the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay that adds the Maxwell® RSC 48 and Maxwell® CSC 48 instruments, along with the Maxwell® RSC Viral Total Nucleic Acid Purification Kit, as options for the tes
(0)
Expanded list of authorized instruments and reagents allows more options for labs running CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay
Labs performing the Centers for Disease Control s (CDC) Flu SC2 Multiplex Assay, a single test to diagnose infection caused by SARS-CoV-2, influenza A, or influenza B, can now use two Promega instruments and a Promega nucleic acid purification kit in the protocol. In a letter dated January 8, 2021, the US Food and Drug Administration (FDA) authorized an amendment to the Emergency Use Authorization (EUA) for the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay that adds the Maxwell RSC 48 and Maxwell CSC 48 instruments, along with the Maxwell RSC Viral Total Nucleic Acid Purification Kit, as options for the test procedure.